Name:
Phone:
E-Mail:
Question:

Research Studies

CATARACT STUDIES:
 
► Akorn 12-150-0007
A Randomized, Parallel-group, Aqueous Humor Pharmocokinetic Bioequivalence Study of Tobramycin (0.3%)/ Dexamethasone (0.1%) Opthalmic Suspension (Akorn, Inc.) and TOBRADEX® (tobramycin 0.3% and dexamethasone 0.1%) ophthalmic suspension (Alcon Laboratories, Inc.) in Subjects Undergoing Cataract Surgery
Participating Physicians: John D. Goosey, M.D., Jeffrey B. Arnoult, MD
Study Coordinator: Caroline Beard (832) 553-7140
► Baush & Lomb 793
A Phase 3, Multicenter, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Uncomplicated Cataract Surgery
Participating Physicians:  John D. Goosey, M.D., Kevin Y. Jong, M.D.        
Study Coordinators: Santa Montelongo (832) 553-7133, Caroline Beard (832) 553-7140
► Alcon C-11-020
A Multicenter, Prospective, Single Arm, Non-Randomized unmasked, post approval study of the AcrySof® IQ Toric Intraocular Lens Models SN6AT6 - SN6AT9
Participating Physicians: Kevin Y. Jong, MD, John Lim, MD
Study Coordinators: Norma Delbosque (832) 280-3635, Santa Montelongo (832) 553-7133
► Baush & Lomb 670 – COMING SOON
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Assessing the Safety and Efficacy of Loteprednol Etabonate Opthalmic Gel, 0.5% versus Prednisolone Acetate Opthalmic Suspension, 1% for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract. 
Participating Physicians: Carlos A. Gonzales, M.D. 
Study Coordinator: Maira Ansari, BS (832) 553-7160

GLAUCOMA STUDIES: 
  
 ► Bausch & Lomb 769
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension – APOLLO Study
Participating Physicians:Richard Ou, MD, John Lim, MD
Study Coordinator: Caroline Beard (832) 553-7140
► Bausch and Lomb 770
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension – LUNAR Study
Participating Physicians: Fiaz Zaman, MD,  Jeffrey B. Arnoult, MD
Study Coordinators: Santa Montelongo (832) 553-7133, Norma Delbosque (832) 280-3635
UVEITIS STUDIES:
 
►  Abbott Protocol M10-877
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Participating Physicians: Susan Wittenberg, MD, Bailey L. Lee MD, Kelly L. Larkin, MD
Study Coordinators: Yvette Degley, CCRC (832) 553-7100, Maira Ansari, BS (832) 553-7160
 
►  Abbott Protocol M10-880
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Inactive Non-Infectious Intermediate-Posterior-, or Pan-uveitis
Participating Physicians: Susan Wittenberg, MD, Bailey L. Lee MD, Kelly L. Larkin, MD
Study Coordinators: Yvette Degley, CCRC (832) 553-7100, Maira Ansari, BS (832) 553-7160 
 
►  Abbott Protocol M11-327
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Participating Physicians: Susan Wittenberg, MD, Bailey L. Lee MD, Kelly L. Larkin, MD
Study Coordinators: Yvette Degley, CCRC (832) 553-7100, Maira Ansari, BS (832) 553-7160
 

DRY EYE STUDIES:
►  Chiltern/Acucela Protocol ACU-RED 301
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects with Dry Eye Syndrome
Participating Physicians: John D. Goosey, MD, Mark C. Vital, MD, Jeffrey D. Lanier, MD, Jeffrey B. Arnoult, MD
Study Coordinator: Santa Montelongo (832) 553-7133, Caroline S. Beard (832) 553-7140
 
BACTERIAL CONJUNCTIVITIS STUDY:
► Bausch & Lomb 801
A Study to evaluate the Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID Compared to Vehicle in the Treatment of Bacterial Conjunctivitis
Participating Physicians: Fiaz Zaman, MD, Carlos A. Gonzales, MD
Study Coordinator: Maira Ansari, BS (832) 553-7160
 
SEVERE VERNAL KERATOCONJUNCTIVITIS STUDY:
► Nova22007
A Multicenter, Randomized, Double-Masked, 3 Parallel Arms, Placebo Controlled Study to Assess the Efficacy and Safety of NOVA22007 1mg/mL (Ciclosporin/Cyclosporine) eye drops, Emulsion Administered in Paediatric Patients with Active Severe Vernal Keratoconjunctivitis with Severe Keratitis
Participating Physicians: Mark C. Vital, MD, Jeffrey D. Lanier, MD,Carlos A. Gonzales, MD
Study Coordinator: Yvette Degley, CCRC (832)553-7100
Amblyopia Studies:

►  PEDIG ATS 17 - ENROLLMENT ENDS IN APRIL
A Randomized Trial of Levodopa as Treatment for Residual Amblyopia
Participating Physician: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177

Strabismus Studies:

►  PEDIG IXT 1
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia
Participating Physician: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177
 
 ► HTS 1
Glasses versus observation for moderate hyperopia in young children.
Participating Physician: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177


Bacterial Conjunctivitis:

► Bausch & Lomb 801
A Study to evaluate the Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID Compared to Vehicle in the Treatment of Bacterial Conjunctivitis
Participating Physician: Aaron M. Miller, MD
Coordinator: Jorie Jackson, CO (832) 553-7177